GL1X · GenesisL1 explorer

MolNFT v1 · #86262 · protein

Crystal structure of C2498 2'-O-ribose methyltransferase rlmm from escherichia COLI in complex with S-adenosylmethionine

4B17 · Ribosomal RNA large subunit methyltransferase M: “Crystal structure of C2498 2'-O-ribose methyltransferase rlmm from escherichia COLI in complex with…”. X-ray diffraction, 2 ligands (SAM, SO4), 3 pockets (best druggability 0.45).…

PDB
4B17
Type
protein
Length
357 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ribosomal RNA large subunit methyltransferase M
EC
2.1.1.186
UniProt
P0ADR6
Ligands
SAM, SO4
Pockets
3 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARibosomal RNA large subunit methyltransferase M (EC 2.1.1.186)protein35733% helix, 23% strandP0ADR6

Ligands and binding sites

  • SAM · S-adenosylmethionine · ligand · chains A
  • SO4 · Sulfate ion · ion · 4 copies · chains A
  • EDO · 1,2-ethanediol · additive · 11 copies · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11330.450.7724empty
2960.360.7513EDO
3580.290.7412EDO

Modifications

Observed in the structure: 1 modified (oxidation).

Compared structures

  • 4B17 · Crystal structure of C2498 2'-O-ribose methyltransferase RlmM from Escherichia coli in… · the same entry in another collection · chain A against A, TM-score 1.00
  • P0ADR6 · AlphaFold monomer V2.0 prediction for ribosomal RNA large subunit methyltransferase M… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.